13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 37 holding rows worth $325,800,008.
- Accession
- 0001420506-23-001564
- Filer
- CIK 1617201
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 37 entries on the cover page, a total value of $325,800,008 stated on the cover page (in dollars after the unit check, H1), rows summing to $325,800,008 with VALUE read as dollars as filed, 13F file number 028-18450. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 877,586 | $35,164,871 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 55,100 | $24,636,863 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,761,468 | $21,428,992 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,500,000 | $17,600,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 675,000 | $17,462,250 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 417,500 | $16,975,550 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 2,550,000 | $16,473,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 170,000 | $16,031,000 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,343,359 | $14,212,738 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 195,670 | $13,197,942 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 5,583,900 | $12,005,385 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 4,651,920 | $11,397,204 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 1,391,848 | $9,353,219 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 110,468 | $9,153,378 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 120,000 | $8,193,600 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 2,000,000 | $8,100,000 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 235,780 | $7,660,492 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 15,000 | $7,209,600 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 118,684 | $6,900,288 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 2,109,620 | $6,582,014 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 734,897 | $5,394,144 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 60,000 | $5,286,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 147,554 | $4,618,440 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 1,700,000 | $4,420,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,557,370 | $4,298,341 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 314,300 | $3,906,749 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 36,030 | $3,758,650 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,083,997 | $3,447,110 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 1,100,000 | $1,980,000 | dollars as filed | |
| TELADOC HEALTH INC | 87918A105 | COM | 76,900 | $1,947,108 | dollars as filed | |
| AGILON HEALTH INC | 00857U107 | COM | 100,000 | $1,734,000 | dollars as filed | |
| TRINET GROUP INC | 896288957 | PUT | 16,900 | $1,604,933 | dollars as filed | put |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 149,511 | $1,254,397 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 324,425 | $765,643 | dollars as filed | |
| ModivCare Inc | 60783X104 | Common Stock | 16,023 | $724,400 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T906 | COM | 80,000 | $671,200 | dollars as filed | call |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 455,302 | $250,507 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-001564 | this filing | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-23-001664 | base | 2023-08-14 | acceptance time not in the bulk data set |